Food and Drug Administration v. R.J. Reynolds Vapor Co. (2024)
- Docket
- 23-1187
- Decided
- 2024-01-01
- Public Good score
- 68 / 100
- Framers' Intent score
- 62 / 100
Summary
Question: <p>Can retailers who would sell a new tobacco product seek judicial review of the FDA’s denial of a manufacturer’s marketing application under the Tobacco Control Act?</p> Conclusion: <p>The Tobacco Control Act’s provision that “any person adversely affected” by the FDA’s denial of a marketing application may seek judicial review extends to retailers who would sell the new tobacco product, not just the manufacturers who applied for approval. Justice Amy Coney Barrett authored the 7-2 majority opinion of the Court.</p> <p>The phrase “adversely affected” is a term of art in administrative law that the Court has consistently interpreted broadly. When Congress uses variations of this phrase across different statutes, the Court presumes it carries the same meaning as in the Administrative Procedure Act—covering anyone “arguably within the zone of interests to be protected or regulated by the statute.” Congress reinforced this broad interpretation by using “any person” rather than limiting review to “the applicant.” The Court’s precedents from other contexts, including employment discrimination and fair housing cases, confirm that “adversely affected” encompasses more than just the direct recipient of agency action. Retailers face a direct, significant impact from denial orders because they lose the opportunity to profit from selling the product and face criminal penalties if they sell it without authorization.</p> <p>The statutory structure confirms Congress intended different scopes for different provisions. While the Act limits challenges to withdrawal of existing approvals to only “the holder of [the] application,” it uses the broader “any person adversely affected” language for initial denials. This deliberate use of materially different terms creates a presumption that Congress intended different meanings. The FDA’s arguments focusing on the application process and confidentiality provisions cannot override the plain language Congress chose for the judicial review provision.</p> <p>Justice Ketanji Brown Jackson authored a dissenting opinion, joined by Justice Sonia Sotomayor, arguing that retailers fall outside the statute’s zone of interests because the premarket approval scheme involves only manufacturers and the FDA, with no mechanism for retailer participation.</p>
Case Brief
Facts
Retailers sought judicial review of the FDA's denial of a manufacturer's application to market a new tobacco product. The FDA denied the application for a new tobacco product, preventing its sale. Retailers argued that the denial directly impacted their ability to profit from selling the product and exposed them to criminal penalties for unauthorized sales. The FDA contended that only the manufacturer seeking approval could challenge the denial.
Procedural History
The U.S. Court of Appeals for the D.C. Circuit affirmed the FDA's denial, holding that retailers lacked standing to challenge the decision. The Supreme Court granted certiorari to resolve whether retailers fall within the 'any person adversely affected' provision for judicial review.
Issue
Does the Tobacco Control Act's provision allowing 'any person adversely affected' by an FDA denial of a marketing application to seek judicial review include retailers who would sell the product, not just the manufacturer who applied for approval?
Holding
Yes. The phrase 'any person adversely affected' in the Tobacco Control Act encompasses retailers who would sell the product, not just the manufacturer who applied for approval.
Rule
In administrative law, the phrase 'adversely affected' is a term of art interpreted broadly across statutes. When Congress uses such language, it presumptively adopts the meaning from the Administrative Procedure Act, covering anyone 'arguably within the zone of interests to be protected or regulated by the statute.' The use of 'any person' further confirms this broad interpretation.
Reasoning
The Court rejected the FDA's argument that 'adversely affected' should be narrowly read to exclude retailers. Congress's use of 'any person' instead of limiting review to 'the applicant' confirms a broad scope. Retailers face direct, significant harm—loss of profit opportunities and risk of criminal penalties—making them squarely within the zone of interests. The statutory distinction between limited challenges to withdrawal of existing approvals (restricted to 'the holder') and broader review for initial denials confirms Congress's intent to include affected third parties like retailers.
Significance
The decision significantly clarifies administrative law standards by affirming a broad interpretation of 'adversely affected' in statutory review provisions, allowing third parties like retailers to challenge agency actions that directly impact their commercial interests. It reinforces judicial deference to congressional language and sets a precedent for interpreting similarly phrased provisions across other federal statutes.
Public Good Analysis
GPT: This decision enhances access to justice for retailers and promotes regulatory transparency by allowing judicial review of FDA decisions. While it supports economic fairness for small businesses, it does not significantly advance public health outcomes as the ruling focuses purely on procedural access without modifying tobacco product safety standards. | Claude: This ruling expands access to judicial review, allowing retailers to challenge FDA decisions regarding new tobacco products. This benefits the public by ensuring more robust oversight of agency actions and preventing potential regulatory overreach, while also promoting fairness for businesses impacted by those actions. However, it could also lead to more litigation, potentially slowing down the FDA’s regulatory processes.
Framers' Intent Analysis
GPT: The ruling relies on modern administrative law canons rather than original meaning, contradicting the framers' limited government philosophy expressed in Madison's Federalist No. 47. The interpretation of 'any person' through post-framing legal developments diverges from their expectation that statutory scope would be narrowly defined in regulatory contexts like tobacco control. | Claude: The Court’s reliance on a broad interpretation of “adversely affected” and citing the established administrative law framework aligns with the Framers’ aim for a system of checks and balances and due process. James Madison, in Federalist No. 44, emphasized the importance of judicial review as a safeguard against legislative overreach, and this decision supports that principle by allowing affected parties to challenge agency rulings. The textualist approach of focusing on the plain meaning of the statutory language also echoes the originalist principles advocated by figures like Justice Story, who believed courts should prioritize the text of the Constitution and statutes.